[144] Arteris, Inc. SEC Filing

AIP filing a Form 144 notice reporting proposed sales of 90,000 shares of Common stock and a series of recent 10b5-1 dispositions.

Rhea-AI Filing Summary

AIP filing a Form 144 notice reporting proposed sales of 90,000 shares of Common stock and a series of recent 10b5-1 dispositions. The excerpt lists multiple sale dates and amounts, including 106,031 and 73,610 shares on March and February 2026.

Key Figures

Proposed sale: 90,000 shares Sale on 03/02/2026: 106,031 shares Sale on 02/26/2026: 73,610 shares +2 more

5 metrics

Proposed sale 90,000 shares Form 144 header showing securities to be sold

Sale on 03/02/2026 106,031 shares 10b5-1 Sales entry with gross proceeds

Sale on 02/26/2026 73,610 shares 10b5-1 Sales entry with gross proceeds

Gross proceeds example $1,825,081.70 Proceeds for 106,031 share sale on 03/02/2026

Filing venue NASDAQ Exchange listed in the filing header

Key Terms

10b5-1, Form 144, co-trustees

3 terms

10b5-1 regulatory

"10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

co-trustees other

"S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 04:35 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001184563
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Arteris, Inc.
SEC File Number	001-40960
Address of Issuer	900 E. Hamilton Ave., Suite 300 Campbell CALIFORNIA 95008
Phone	4084707300
Name of Person for Whose Account the Securities are To Be Sold	S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	90000	1936800.00	45467261	04/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/28/2020	Previously Exercised Stock Options	Issuer			90000	12/28/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	03/04/2026	3690	62786.46
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	03/02/2026	106031	1825081.70
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	02/27/2026	11762	200046.65
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	02/26/2026	73610	1261795.28
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	02/25/2026	4907	83419.50

144: Remarks and Signature

Remarks
Date of Notice	04/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ S. Atiq Raza
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)